Exodus Point Capital Management, LP Applied Therapeutics Inc. Transaction History
Exodus Point Capital Management, LP
- $13.1 Billion
- Q1 2024
A detailed history of Exodus Point Capital Management, LP transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 60,795 shares of APLT stock, worth $318,565. This represents 0.0% of its overall portfolio holdings.
Number of Shares
60,795Holding current value
$318,565% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding APLT
# of Institutions
100Shares Held
94MCall Options Held
5.83MPut Options Held
231K-
Franklin Resources Inc San Mateo, CA10.6MShares$55.4 Million0.02% of portfolio
-
Vr Adviser, LLC New York, NY9.08MShares$47.6 Million5.3% of portfolio
-
Perceptive Advisors LLC New York, NY8.01MShares$41.9 Million1.14% of portfolio
-
Janus Henderson Group PLC London, X06.41MShares$33.6 Million0.02% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA6.11MShares$32 Million24.19% of portfolio
About Applied Therapeutics Inc.
- Ticker APLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,020,700
- Market Cap $252M
- Description
- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...